SCHEMBL14478654

SCHEMBL14478654

c1ccc(-c2cnc3c4ccccc4c4cc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)c5ccccc5c4c3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.38
▸ MAPK10 P53779 1/20 0.38
▸ AXL P30530 6/20 0.38
▸ CDK8 P49336 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ TNIK Q9UKE5 1/20 0.38
▸ PSMB5 P28074 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ MET P08581 1/20 0.36
▸ PARP1 P09874 1/20 0.35
▸ SGK1 O00141 2/20 0.34
▸ GSK3B P49841 3/20 0.34
▸ PDGFRB P09619 1/20 0.34
▸ PDGFRA P16234 1/20 0.34
▸ GSK3A P49840 1/20 0.34
▸ ACVR1 Q04771 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14478659 0.91 AXL (0.37) KDM4EMAPK10AXLCDK8NPC1
SCHEMBL14478648 0.86 ACVR1 (0.41) KDM4EMAPK10NPC1RAB9ASMN1; SMN2
SCHEMBL20624076 0.84 MEN1 (0.44) KDM4ENPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL20623678 0.84 MEN1 (0.44) KDM4ENPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL20623633 0.84 MEN1 (0.44) KDM4ENPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL20623681 0.84 L3MBTL1 (0.45) KDM4ENPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL20624074 0.84 L3MBTL1 (0.45) KDM4ENPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL14478673 0.84 ADORA2A (0.40) KDM4ENPC1RAB9ASMN1; SMN2MET
SCHEMBL14478631 0.83 TOP1 (0.40) KDM4ESMN1; SMN2NFKB1LMNAMAPT
SCHEMBL20624440 0.81 MEN1 (0.40) KDM4ENPC1RAB9ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8986855-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2015-03-24 — — US disclosed
US-8986855-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2015-03-24 — — US disclosed
US-8951649-B2 — — 2015-02-10 — — US disclosed
US-8951649-B2 — — 2015-02-10 — — US disclosed
US-20130001529-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-01-03 — — US disclosed
US-20130001529-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130001529-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, ORC3, NR2E3 KDM4E 2671/4885MAPK10 3789/4885AXL 924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback